Illumina MiSeq i100Plus sequencing system

PA #2 6/16 approved The purpose of the request is to purchase a new model desktop genomic sequencing system from Illumina that has better technology and build, higher throughput, greater efficiency and accuracy, and less cost per genome compared to the older models. The new model of sequencing instrument shall assist the OAMT scientists on the in-silico design and development of all FDA sequencing applications for foodborne pathogens (bacteria such as Salmonella spp., Listeria monocytogenes and STEC, and viruses and parasites). We will also utilize the instrument to develop and optimize next generation sequencing laboratory protocols and to compare new applications (such as Targeted Amplicon Sequencing) with other genomic methods like whole genome and metagenome sequencing. One instrument for MOD1 (DFES) & one instrument for CPK1 (DFSG) & one instrument for Moffett (DFPST - unfunded)

Estimated value

> $25K and < $250K

Est. solicitation date

Feb 1, 2026

Anticipated award

Apr 1, 2026

• NAICS423490
• PSC423490